E-LIB Suche - Ergebnisse für: Chari, Sharmila A.

1

A rapid review of literature on first episode psychosis amo..:

Kazi, Asiya K. ; McDonnell, Carrie B. ; Chari, Sharmila A..
Psychosis. , 2024

Link: https://doi.org/10.1080/..

2

Military chaplains and mental health clinicians: Overlappin..:

Cooper, Denise C. ; Evans, Christian A. ; Chari, Sharmila A...
Psychological Services. 20 (2023) 1 - p. 56-65 , 2023

Link: https://doi.org/10.1037/..

3

Corrigendum to "A randomized, controlled study of computer-..:

Given, Barbara K. ; Wasserman, John D. ; Chari, Sharmila A...
Brain and Language. 109 (2009) 1 - p. 49 , 2009

Link: https://doi.org/10.1016/..

4

A randomized, controlled study of computer-based interventi..:

Given, Barbara K. ; Wasserman, John D. ; Chari, Sharmila A...
Brain and Language. 106 (2008) 2 - p. 83-97 , 2008

Link: https://doi.org/10.1016/..

5

Fully optimized discrimination of physiological responses t..:

Kruglikov, Stepan Y ; Chari, Sharmila ; Rapp, Paul E...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2535922. , 2008

Link: http://www.ncbi.nlm.nih...

6

P-801 Sub-endometrial administration of angiogenic precurso..:

Aruna, R ; Aparna, D ; Vasanthi, P...
Human Reproduction. 39 (2024) Supplement_1 - p. , 2024

Link: https://doi.org/10.1093/..

7

Daratumumab-based quadruplet therapy for transplant-eligibl..:

Callander, Natalie S. ; Silbermann, Rebecca ; Kaufman, Jonathan L....
Blood Cancer Journal. 14 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

8

Post hoc analysis of daratumumab plus lenalidomide, bortezo..:

Nooka, Ajay K. ; Kaufman, Jonathan L. ; Rodriguez, Cesar...
British Journal of Haematology. 204 (2024) 6 - p. 2227-2232 , 2024

Link: https://doi.org/10.1111/..

9

Health‐related quality of life in transplant‐eligible patie..:

Silbermann, Rebecca ; Laubach, Jacob ; Kaufman, Jonathan L....
American Journal of Hematology. 99 (2024) 7 - p. 1257-1268 , 2024

Link: https://doi.org/10.1002/..

10

Daratumumab in transplant-eligible patients with newly diag..:

Chari, Ajai ; Kaufman, Jonathan L. ; Laubach, Jacob...
Blood Cancer Journal. 14 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

11

P-164 Reduction in disease symptoms/impacts after daratumum..:

Silbermann, Rebecca ; Laubach, Jacob ; Kaufman, Jonathan...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S125-S126 , 2023

Link: https://doi.org/10.1016/..

12

Daratumumab plus lenalidomide, bortezomib and dexamethasone..:

Sborov, Douglas W. ; Baljevic, Muhamed ; Reeves, Brandi...
British Journal of Haematology. 199 (2022) 3 - p. 355-365 , 2022

Link: https://doi.org/10.1111/..

13

Daratumumab plus lenalidomide/bortezomib/dexamethasone in B..:

Nooka, Ajay K. ; Kaufman, Jonathan L. ; Rodriguez, Cesar...
Blood Cancer Journal. 12 (2022) 4 - p. , 2022

Link: https://doi.org/10.1038/..

14

P-219: Daratumumab (DARA) + lenalidomide/bortezomib/dexamet..:

Nooka, Ajay ; Kaufman, Jonathan ; Rodriguez, Cesar...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S155-S156 , 2022

Link: https://doi.org/10.1016/..

15

A Plain Language Summary of Daratumumab Plus Lenalidomide/B..:

Nooka, Ajay K ; Kaufman, Jonathan L ; Rodriguez, Cesar...
Future Oncology. 18 (2022) 40 - p. 4443-4456 , 2022

Link: https://doi.org/10.2217/..